Test Predicts Cognitive Decline in Parkinson's Disease

(MedPage Today) -- Kinetic measures of a cerebrospinal fluid (CSF) biomarker test predicted cognitive decline in Parkinson's disease and distinguished it from progressive supranuclear palsy (PSP), an analysis of data from three cohorts showed...